MedVi vs bmiMD: Semaglutide vs Tirzepatide Pricing & Access
MedVi vs bmiMD is a choice between a semaglutide-focused telehealth program and a tirzepatide subscription with multi-month pricing. Early verdict: choose MedVi if you want a simple online intake, no clinic visits, and a promotional first month starting at $179; choose bmiMD if you prefer compounded tirzepatide and lower long-term monthly rates as low as $139 with prepaid plans.
Start MedVi semaglutide at $179
Quick comparison: what differs most between MedVi vs bmiMD
This comparison focuses on the most distinctive supported differences: medication type offered, starting price and multi-month pricing, online process and clinic visits, shipping and support, and regulatory notes about compounded medications.
Medication type and dosing options
MedVi offers clinically dosed compounded semaglutide only. bmiMD offers compounded tirzepatide, a GLP-1/GIP option. Both use compounded medication models; both sources state compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
Price structure and multi-month plans
MedVi advertises a winter promotional starting price of $179 for the first month, including fast, free shipping, with an ongoing standalone month at $299 and a three-month plan at $649 (about $216/month). bmiMD lists tiered subscription pricing with four billing options: $179 month-to-month; $159 for three months; $149 for six months; and $139 for a 12-month plan, with free shipping on every subscription order. bmiMD emphasizes lower long-term monthly equivalents but notes the lowest price requires a longer commitment and a total prepaid charge should be confirmed.
Process, clinician review, and visits
MedVi operates a simple online intake with no clinic visits needed; an OpenLoop Health clinician reviews cases after checkout and retains prescribing discretion. bmiMD provides clinician-reviewed online treatment and 24/7 clinician access; treatment is available only when a licensed clinician determines it is medically appropriate. Both state medication is prepared at licensed pharmacies and shipped to your door.
Support, shipping, and guarantees
MedVi highlights 24/7 support from certified medical professionals and fast, free shipping for the promotional month. bmiMD also offers 24/7 clinician access and free subscription shipping. bmiMD states a “100% Risk Free” refund if not eligible for the program, described as 100% refundable if not eligible for program. MedVi notes a guarantee phrase on their site but specifies eligibility and insurance/copay determinations occur at time of visit.
Comparison table: MedVi vs bmiMD
| Criteria | MedVi | bmiMD |
|---|---|---|
| Medication offered | Compounded semaglutide only | Compounded tirzepatide (GLP-1/GIP) |
| Starting price | Promotional first month $179; ongoing standalone month $299 | $179 month-to-month; as low as $139/mo with 12-month plan |
| Multi-month pricing | Three-month plan $649 (about $216/mo) | 3, 6, 12 month options with lower monthly equivalents |
| Clinic visits | No clinic visits required; online intake and clinician review | Online clinician review required; treatment only if licensed clinician approves |
| Shipping & support | Fast, free shipping on promo month; 24/7 certified medical support | Free shipping on subscription orders; 24/7 clinician access; online refills |
| Regulatory note | Compounded meds not FDA-approved; filled at licensed pharmacies | Compounded meds not FDA-approved; prepared in state-licensed pharmacies |
What the sources explicitly do not supply
The sources do not supply independent published outcome guarantees or comprehensive availability details by state beyond the statements captured. Do not assume insurance coverage; both providers operate primarily as cash-pay for compounded products and state that insurance may not cover compounded medications.
See bmiMD tirzepatide plans from $139
Risk and regulatory context
Both MedVi and bmiMD use compounded medications and explicitly note these are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. MedVi additionally notes that compounded GLP-1s are produced in FDA-regulated facilities but are not FDA-approved and that provider discretion guides prescribing. bmiMD states compounded medications are not FDA-approved and advises confirming prepaid totals when choosing longer plans.
Review MedVi program details and clinician review
How to choose between MedVi vs bmiMD
Choose MedVi if you want a semaglutide-only program with a simple online intake, no clinic visits, promotional first-month pricing at $179 with fast, free shipping, and 24/7 certified medical support. Choose bmiMD if you prefer compounded tirzepatide, value lower long-term monthly equivalents as low as $139 with prepaid plans, and want multi-month subscription options with free shipping and 24/7 clinician access.
Compare bmiMD subscription options now
In summary, MedVi vs bmiMD comes down to medication type and pricing preferences. MedVi emphasizes a promotional entry price and a no-clinic process for compounded semaglutide. bmiMD emphasizes tirzepatide, multi-month pricing, and lower long-term monthly costs. Review clinician eligibility, total prepaid charges for any long-term plan, and the regulatory notes about compounded medications before enrolling.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
